Dysregulated glycolysis as an oncogenic event

Area of Science:

• Biochemistry
• Cancer Biology
• Metabolic Pathways

Background:

• The Warburg effect, or enhanced glycolysis, is a hallmark of cancer metabolism.
• This metabolic shift is linked to crucial cancer properties like adaptation to stress and biomass synthesis.

Purpose of the Study:

• To review the intricate relationship between enhanced glycolysis and oncogenic events in cancer.
• To highlight key molecular regulators and signaling pathways involved in cancer metabolism.

Main Methods:

• Literature review of recent advances in cancer metabolism research.
• Analysis of oncogenic molecules and signaling pathways influencing glycolysis.
• Identification of novel oncogene candidates regulating glycolytic enzymes.

Main Results:

• The Warburg effect is intrinsically coupled with cancer cell adaptation, survival, and proliferation.
• Oncogenic pathways (e.g., c-Myc, p53, insulin/Ras) mediate the link between glycolysis and cancer.
• Several glycolytic regulators (e.g., HIF pathway, sirtuins, AMPK, PKM2) are implicated as oncogenes.

Conclusions:

• Understanding the interplay between glycolysis and oncogenesis is crucial for cancer research.
• Targeting metabolic pathways offers potential therapeutic strategies for cancer treatment.